Keyphrases
Metoprolol
100%
Vasovagal Syncope
100%
Older Subjects
100%
Syncope
37%
Pharmacological Therapy
25%
Placebo
25%
Randomized Placebo-controlled Trial
12%
Dropout
12%
Cost Analysis
12%
Older Patients
12%
Therapeutic Potential
12%
First Recurrence
12%
Young Patients
12%
Adrenergic Receptor Antagonist
12%
Event Rate
12%
40 Years Old
12%
Placebo-controlled Clinical Trial
12%
Power Calculation
12%
Presyncope
12%
Hazard Rate
12%
Intention-to-treat
12%
On-treatment Analysis
12%
Patient's Will
12%
Poor Quality of Life
12%
Quality of Life Analysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Faintness
100%
Metoprolol
100%
Placebo
30%
Pharmacotherapy
20%
Controlled Clinical Trial
10%
Placebo-Controlled Study
10%
Recurrent Disease
10%
Adrenergic Receptor Blocking Agent
10%
Presyncope
10%
Neuroscience
Metoprolol
100%
Placebo
50%
Drug Therapy
25%
Receptor Antagonist
12%
Adrenergic Receptor
12%